Valuation dashboard for Quest Diagnostics Incorporated (DGX) with P/E 25.70, P/B 3.59, EV/EBITDA N/A and dividend yield 1.35%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing.
Analysis Summary
Quest Diagnostics Incorporated reported revenue of $11.04B in the most recent fiscal year, growing at a 5-year CAGR of 3.2%. Net income reached $992.0M, with a -7.1% 5-year CAGR.
Trailing-twelve-month margins: gross margin 33.1%, operating margin 14.1%, net margin 9.2%.
Balance sheet quality for DGX: current ratio of 1.0. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 25.70 |
| Price / Book | 3.59 |
| Dividend Yield | 1.35% |
Valuation Models
| DCF Fair Value | $187.06 |
| vs Current Price | -24.3% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| DGX | Quest Diagnostics Incorporated | $27.3B | 25.70 | 3.59 | |
| UTHR | United Therapeutics Corporation | $21.2B | 16.49 | 3.32 | |
| INCY | Incyte Corporation | $25.3B | 15.44 | 3.96 | 29.7% |
| ILMN | Illumina, Inc. | $34.6B | 45.56 | 13.12 | 31.1% |
| MEDP | Medpace Holdings, Inc. | $17.2B | 37.44 | 42.48 | 110.1% |
| ICLR | ICON Public Limited Company | $13.3B | 40.45 | 1.42 | 3.5% |
| LH | Labcorp Holdings Inc. | $26.6B | 26.99 | 3.12 | 11.6% |
| WAT | Waters Corporation | $31.3B | 106.22 | 2.76 | 1.9% |
Price
| Price | $247.08 |
| Market Cap | $27.3B |
| Exchange | NYSE |
| Country | US |
Profitability
| Gross Margin | 33.15% |
| Operating Margin | 14.14% |
| Net Margin | 9.19% |
Related companies: ICLR · ILMN · INCY · LH · MEDP · THC · UTHR
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of DGX: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks